NAMPT and heart failure: NAD+ concentration is decreased in failing human hearts (17), and expression of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme for NAD+ synthesis, is downregulated during heart failure and in myocardial ischemic injury (24).